Fernway's Traveler e-cigarette introduces recycling program

Jul.19.2022
Fernway's Traveler e-cigarette introduces recycling program
Fernway introduces a recycling program for its new Traveler e-cigarette, promoting sustainability in the cannabis industry.

Fernway is launching a recycling program as part of their green initiative to coincide with the release of their new Traveler electronic cigarette.


The Fernway recycling program is a cannabis e-cigarette hardware recycling program offered by the state of Massachusetts. Users who purchase the Fernway Traveler from licensed pharmacies can bring the finished product back to the pharmacy and deposit it into a secure Fernway Dropbox. Fernway will then coordinate the recycling and reuse of the product in partnership with GAIACA, a leader in providing compliant solutions for cannabis waste.


Kit Gallant, CEO and co-founder of Fernway, stated, "As we develop new products, we always prioritize our customers. Therefore, we are pleased to make it easy for them to recycle their Traveler and join the conversation about sustainability in the cannabis industry.


When electronic cigarettes are sold as "disposable items," it poses a problem. It encourages people to throw them in the trash, which can contribute to environmental waste. The vast majority of our customers say that wastefulness is their biggest hesitation when it comes to electronic cigarettes, but it doesn't have to be. Customers no longer have to choose between having an excellent marijuana experience and being environmentally conscious. That's why, as part of our launch of the Fernway Traveler, we've created the Fernway Recycling Program, which is why we say the Traveler is not "disposable" but "recyclable.


Fernway Traveler is a disposable marijuana e-cigarette with an integrated battery. Gallant, the company's founder, stated, "We designed Fernway Traveler to provide customers with an undeniable high-quality product. It has various unique features such as a charging port, smart power meter, and precision-engineered oil compartment, which extends the lifespan of the oil. However, in order to truly deliver the top-notch experience people expect from Fernway, we are embracing and investing in sustainability. This is why we have created the Fernway Recycling Program - to fulfill our commitment to customers that the Fernway brand means quality, and we will always go the extra mile.


The Fernway Traveler recycling program will be launched in pharmacies across the state in July 2022.


Sorry, I cannot complete this task without a specific text or sentence to translate. Please provide more information.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Around 58,000 counterfeit vapes and tobacco seized from UK 's Hampshire streets over the past year
Around 58,000 counterfeit vapes and tobacco seized from UK 's Hampshire streets over the past year
UK's Hampshire Trading Standards says around 58,000 counterfeit vapes and tobacco products have been seized from Hampshire over the last year. Richard Strawson, Hampshire’s Head of Trading Standards, said officers often find vape products disguised under fake branding.
Jan.05 by 2FIRSTS.ai
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
UPC Court of Appeal refuses to revive VMR’s European vape patent, upholding lack of inventiveness
UPC Court of Appeal refuses to revive VMR’s European vape patent, upholding lack of inventiveness
The Unified Patent Court’s Court of Appeal declined on Dec. 29 to revive a European patent held by VMR Products LLC, upholding a finding that the patent is not inventive over earlier devices. The decision said adding a window in the vape’s outer shell to reveal the internal cartridge holding vape liquid was an obvious, routine adaptation based on an earlier U.S. patent and general knowledge.
Jan.06 by 2FIRSTS.ai
Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
Nepal: 80 cartons of e-cigarettes seized, valued at US$150,000
In Nepal’s Mustang district, authorities seized 80 cartons of e-cigarettes valued at NPR 22,459,320 (approximately US$150,000) in Lomanthang Rural Municipality-4, Nechung, and detained a 32-year-old man, Pema Lama. The account says the e-cigarettes were allegedly brought illegally from China three to four days earlier and loaded near the Korala Nepal–China border point before being intercepted.
Jan.13 by 2FIRSTS.ai
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
British American Tobacco said 2026 will mark a return to its mid-term growth algorithm, but CEO Tadeu Marroco stressed that deliverywill depend heavily on enforcement against illicit vapour products in the United States. Speaking at the FY2025 results call, he positioned Modern Oral as the company’s primary structural growth engine, reframed accelerating cigarette declines through “poly-usage,” and reinforced capital discipline with an expanded share buyback plan.
Feb.12
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24